AM

Ajaroddin Mahamad Shaikh

Active Director Director DIN 11487667
DIN 11487667 First appointment Jan 2026 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Ajaroddin Mahamad Shaikh

Data last updated:

Ajaroddin Mahamad Shaikh is a Director at Lexit Pharmaceuticals Private Limited (since 2026). The company operates in Pharma.

DIN 11487667
Primary Designation Director
Industry Pharma
First Appointment 16 Jan 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director16 Jan 20262026Active

Board colleagues of Ajaroddin Mahamad Shaikh

Directorship timeline

Open interactive timeline →
Lexit Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Ajaroddin Mahamad Shaikh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ajaroddin Mahamad Shaikh

Ajaroddin Mahamad Shaikh currently holds 1 directorship: Lexit Pharmaceuticals Private Limited (Director, since 16 Jan 2026).

Ajaroddin Mahamad Shaikh was first appointed on 16 Jan 2026 as Director at Lexit Pharmaceuticals Private Limited.

The current boards of Ajaroddin Mahamad Shaikh's companies include Anil Manikrao Farkande (Lexit Pharmaceuticals Private Limited), Datta Babruwan Karande (Lexit Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available